Covered recipient · General Payments record
THEODORE TRUSEVICH
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2022
$3,309.61
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $144.22 | 9 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $42.42 | 3 |
| Amarin Pharma Inc. | $32.22 | 2 |
| Amgen Inc. | $19.45 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $17.41 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.62 | 1 |
| CVRx Inc. | $16.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amarin Pharma Inc. | $15.69 | 02/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 913923411 | CMS |
| Amarin Pharma Inc. | $16.53 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 913964707 | CMS |
| Amgen Inc. | $19.45 | 03/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939393149 | CMS |
| Boston Scientific Corporation | $17.41 | 03/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 916867577 | CMS |
| CVRx, Inc. | $16.10 | 01/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 947230135 | CMS |
| Janssen Pharmaceuticals, Inc | $16.73 | 02/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886940753 | CMS |
| Janssen Pharmaceuticals, Inc | $12.23 | 02/09/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886940751 | CMS |
| Janssen Pharmaceuticals, Inc | $13.46 | 03/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886940755 | CMS |
| Novartis Pharmaceuticals Corporation | $16.62 | 02/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894424637 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.